The partnership provides for five biosimilars – two for oncology and three for treating autoimmune diseases – in certain emerging markets, including South Africa. • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
